Sponsored Multimedia

Most Recent

image: Enzo: Immunohistochemistry Solutions

Enzo: Immunohistochemistry Solutions

By | March 28, 2017

Ensure that your message is clear with the right immunohistochemistry tools.

0 Comments

image: ProteinSimple: Milo: Single-Cell Western

ProteinSimple: Milo: Single-Cell Western

By | March 24, 2017

Meet Milo. The world’s first Single-Cell Western platform.

0 Comments

image: LabQuiz: iPSCs

LabQuiz: iPSCs

By | March 22, 2017

Are you the lab expert on induced pluripotent stem cells (iPSCs)? Take our test to find out how much you really know.

0 Comments

image: BioLegend: Empower your Research

BioLegend: Empower your Research

By | March 6, 2017

Cancer research is complicated. Build your experiments on solid ground. 

0 Comments

image: Microglial Activation: Understanding Neuroinflammation's Origins

Microglial Activation: Understanding Neuroinflammation's Origins

By |
Event Date: May 10 2017

The Scientist is bringing together a panel of experts to review the latest understanding of microglial-induced neuroinflammation and to share their research on mechanisms and medicine. Attendees will have the opportunity to interact with the experts, ask questions, and seek advice on topics that are related to their research.

0 Comments

image: Going Viral: Where Busy Scientists go to Meet the Virus of Their Dreams

Going Viral: Where Busy Scientists go to Meet the Virus of Their Dreams

By | March 1, 2017

Choosing a viral delivery system is a bit like choosing a partner. Do you share goals? Are you truly compatible? Download our "Going Viral" poster to find the right viral system for you!

0 Comments

image: Meet Your Next Milestone With CRISPR

Meet Your Next Milestone With CRISPR

By | March 1, 2017

With 80+ years' experience in mouse genetics, The Jackson Laboratory has the capability to modify strains that are relevant in preclinical drug discovery and development with unmatched success rates. With our model generation, breeding, phenotyping, and in vivo testing under one roof, you can save months and meet that next milestone. Download this poster from JAX to learn more.

0 Comments

image: Trends in Fibrosis Research and Drug Discovery: Nonalcoholic Steatohepatitis (NASH)

Trends in Fibrosis Research and Drug Discovery: Nonalcoholic Steatohepatitis (NASH)

By |
Event Date: April 26 2017

The Scientist is bringing together a panel of experts to discuss the industry-wide trends in cell signaling analysis and molecular pharmacology that are informing the search for NASH therapies, to explore the challenges of identifying therapeutic targets for multifactorial, lifestyle-induced diseases, and to share the latest details of their NASH-directed R&D efforts.

0 Comments

image: Erasing Epigenetic Marks: Eternal Sunshine of the Spotless Epigenome

Erasing Epigenetic Marks: Eternal Sunshine of the Spotless Epigenome

By |
Event Date: April 19 2017

The Scientist is bringing together a panel of experts who will share their research into editing the epigenome.  Attendees will have an opportunity to interact with the experts, ask questions, and seek advice on topics related to their research.  

0 Comments

image: LabQuiz: How Well do you Know Your Culture Media?

LabQuiz: How Well do you Know Your Culture Media?

By | February 22, 2017

Do you know the real story behind your culture-media additives? Find out if you're a media maven or a cell-nutrition newbie in our LabQuiz!

0 Comments

Popular Now

  1. UC Berkeley Receives CRISPR Patent in Europe
    Daily News UC Berkeley Receives CRISPR Patent in Europe

    The European Patent Office will grant patent rights over the use of CRISPR in all cell types to a University of California team, contrasting with a recent decision in the U.S.

  2. DNA Replication Errors Contribute to Cancer Risk
  3. Should Healthy People Have Their Exomes Sequenced?
    Daily News Should Healthy People Have Their Exomes Sequenced?

    With its announced launch of a whole-exome sequencing service for apparently healthy individuals, Ambry Genetics is the latest company to enter this growing market. But whether these services are useful for most people remains up for debate.  

  4. Rethinking a Cancer Drug Target
    Daily News Rethinking a Cancer Drug Target

    The results of a CRISPR-Cas9 study suggest that MELK—a protein thought to play a critical role in cancer—is not necessary for cancer cell survival.

Business Birmingham